Insider Transactions in Q4 2024 at Bluebird Bio, Inc. (BLUE)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2024
|
Richard A Colvin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,824
-1.68%
|
$0
$0.42 P/Share
|
|
Dec 10
2024
|
Andrew Obenshain President and CEO |
SELL
Open market or private sale
|
Direct |
971
-0.26%
|
$0
$0.42 P/Share
|
|
Nov 06
2024
|
Najoh Tita Reid |
BUY
Grant, award, or other acquisition
|
Direct |
24,900
+34.08%
|
-
|
|
Nov 06
2024
|
Elisabeth Leiderman |
BUY
Grant, award, or other acquisition
|
Direct |
24,900
+34.56%
|
-
|
|
Nov 06
2024
|
John O Agwunobi |
BUY
Grant, award, or other acquisition
|
Direct |
24,900
+32.65%
|
-
|
|
Nov 06
2024
|
Charlotte Jones Burton |
BUY
Grant, award, or other acquisition
|
Direct |
24,900
+36.42%
|
-
|
|
Nov 06
2024
|
Richard A. Paulson |
BUY
Grant, award, or other acquisition
|
Direct |
24,900
+45.72%
|
-
|
|
Nov 06
2024
|
Nick Leschly |
BUY
Grant, award, or other acquisition
|
Direct |
24,900
+7.31%
|
-
|
|
Nov 06
2024
|
Mark Vachon |
BUY
Grant, award, or other acquisition
|
Direct |
24,900
+33.27%
|
-
|